Grantham, Mayo, Van Otterloo & Co (GMO)’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $99.9M | Buy |
|
|||||
|
2025
Q1 | $82.9M | Sell |
|
|||||
|
2024
Q4 | $140M | Buy |
|
|||||
|
2024
Q3 | $152M | Buy |
|
|||||
|
2024
Q2 | $121M | Buy |
|
|||||
|
2024
Q1 | $64.7M | Sell |
|
|||||
|
2023
Q4 | $62.2M | Buy |
|
|||||
|
2023
Q3 | $45.9M | Buy |
|
|||||
|
2023
Q2 | $22.5M | Buy |
|
|||||
|
2023
Q1 | $5.65M | Sell |
|
|||||
|
2022
Q4 | $10.7M | Sell |
|
|||||
|
2022
Q3 | $63M | Buy |
|
|||||
|
2022
Q2 | $84.8M | Buy |
|
|||||
|
2022
Q1 | $23.2M | Buy |
|
|||||
|
2021
Q4 | $10.3M | Sell |
|
|||||
|
2021
Q3 | $11M | Sell |
|
|||||
|
2021
Q2 | $23.6M | Buy |
|
|||||
|
2021
Q1 | $8.62M | Buy |
|
|||||
|
2020
Q4 | $1.44M | Buy |
|
|||||
|
2020
Q3 | $1.42M | Sell |
|
|||||
|
2020
Q2 | $5.05M | Sell |
|
|||||
|
2020
Q1 | $17.4M | Buy |
|
|||||
|
2019
Q4 | $9.23M | Sell |
|
|||||
|
2019
Q3 | $33M | Sell |
|
|||||
|
2019
Q2 | $84.2M | Sell |
|
|||||
|
2019
Q1 | $103M | Sell |
|
|||||
|
2018
Q4 | $95.7M | Buy |
|
|||||
|
2018
Q3 | $97.7M | Buy |
|
|||||
|
2018
Q2 | $68.8M | Buy |
|
|||||
|
2018
Q1 | $59M | Buy |
|
|||||
|
2017
Q4 | $37.8M | Buy |
|
|||||
|
2017
Q3 | $33.6M | Buy |
|
|||||
|
2017
Q2 | $13.1M | Sell |
|
|||||
|
2017
Q1 | $25.7M | Sell |
|
|||||
|
2016
Q4 | $70.1M | Buy |
|
|||||
|
2016
Q3 | $67.4M | Buy |
|
|||||
|
2016
Q2 | $6.71M | Buy |
|
|||||
|
2016
Q1 | $3.24M | Buy |
|